QuadraMed Corporation Market Share Analysis

Publisher Name :
Date: 12-Dec-2012
No. of pages: 45
Inquire Before Buying

QuadraMed Corporation Market Share Analysis

Summary

GlobalData’s new report, “QuadraMed Corporation Market Share Analysis” provides in-depth information on QuadraMed Corporation.’s market position in the clinical IT systems market. The report also provides data and information on the overall competitive landscape within the clinical IT systems market. The report is supplemented with global corporate-level profile with information on the company’s business segments, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

- Global company shares (in Revenues) information for the clinical IT systems market.
- QuadraMed Corporation.’s company shares (in Revenues) information for all the key countries the company has presence in – Canada and United States.
- QuadraMed Corporation.’s company shares (in Revenues) information for the clinical IT systems market.
- All the key data-points are for 2011 and cover all the key region – North America.
- Global corporate-level profile with information on the company’s business segments, major products and services, competitors, and locations and subsidiaries.
- The company profile is also supplemented with a SWOT Analysis with in-depth information and analysis of the company’s value proposition and the business climate it operates in.
- Comprehensive coverage of the latest financial deals involving the company and its subsidiaries.

Reasons to buy

- Develop sales and marketing strategies by identifying who-stands-where in the markets, QuadraMed Corporation.’s operates in.
- Plan your competition strategies by identifying the company’s shares in the markets and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to QuadraMed Corporation.’s market positions.

QuadraMed Corporation Market Share Analysis

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
3 Definitions of Markets/Categories Covered 7
3.1 Healthcare IT 7
3.1.1 Clinical IT Systems 7
4 Company Snapshot 8
4.1 Key Information 8
4.2 Company Overview 8
4.3 SWOT Snapshot 8
4.4 Business Overview 9
4.5 Major Products and Services 10
4.5.1 Overview 10
5 History 11
6 SWOT Analysis 13
6.1 Overview 13
6.2 QuadraMed Corporation Strengths 13
6.2.1 Industry Recognitions 13
6.2.2 Exhaustive Suite of Consulting Services 14
6.2.3 Extensive Product Range 14
6.3 QuadraMed Corporation Weaknesses 14
6.3.1 Involvement in Legal Proceedings 14
6.4 QuadraMed Corporation Opportunities 15
6.4.1 Growth Prospects: Healthcare IT 15
6.4.2 New Business Contracts 15
6.4.3 Strategic Acquisition 15
6.5 QuadraMed Corporation Threats 16
6.5.1 Government Regulations 16
6.5.2 Competitive Landscape 16
6.5.3 Rapid Technological Advancements 16
7 Competitors 17
8 Competitive Landscape 19
8.1 Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
8.2 QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Region, Market Share (2011) 21
8.3 QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Country, Market Share (2011) 22
9 Key Employees 23
10 Key Employee Biographies 24
11 Company Statement 25
12 Locations And Subsidiaries 26
12.1 Head Office 26
13 Financial Deals Landscape 27
13.1 QuadraMed Corporation, Deals Volume Summary, 2006 to YTD 2012 27
14 QuadraMed Corporation Detailed Deal Summary 29
14.1 Asset Purchase 29
14.1.1 QuadraMed Acquires Healthcare Solutions Business From NCR 29
14.2 Private Equity 31
14.2.1 Francisco Partners Completes Acquisition Of Quadramed 31
14.3 Asset Transactions 33
14.3.1 Nuance Communications To Acquire Quantim, Health Information Management Business Of QuadraMed 33
15 Recent Developments 35
15.1 Strategy And Business Planning 35
15.1.1 Aug 16, 2010: QuadraMed Partners With CPMRC To Provide Evidence-Based Clinical Content Within Their Healthcare IT Solutions 35
15.2 Corporate Communications 36
15.2.1 Jan 05, 2010: QuadraMed Appoints Thomas Dunn As Senior Vice President Of Sales And Marketing 36
15.2.2 Sep 01, 2009: QuadraMed Appoints Bonnie Cassidy As Vice President, HIM Consulting Services 36
15.2.3 Jul 27, 2009: QuadraMed Appoint Duncan James As CEO 37
15.3 Product News 37
15.3.1 Oct 26, 2009: QuadraMed CPR Receives License From Four Organizations 37
15.3.2 Jul 07, 2008: QuadraMed Announces General Availability Of Enhanced Version Of QCPR 38
15.4 Other Significant Developments 38
15.4.1 May 11, 2011: QuadraMed Renews Contract With NYCHHC For EHR Upgrade And Support 38
15.4.2 Dec 20, 2010: Texas Organization Of Rural & Community Hospitals Foundation Prepares For ICD-10 Transition With QuadraMed's Products And Services 39
16 Appendix 40
16.1 Research Methodology 41
16.2 Secondary Research 41
16.3 Primary Research 42
16.4 Models 42
16.5 Forecasts 42
16.6 Expert Panels 43
16.7 GlobalData Consulting 43
16.8 Currency Conversion 44
16.9 Contact Us 45
16.10 Disclaimer 45

1.1 List of Tables
Table 1: QuadraMed Corporation, Key Information, 2011 8
Table 2: QuadraMed Corporation, SWOT Analysis, 2011 13
Table 3: Healthcare IT (Clinical IT Systems), Global, Company Share by Revenue ($m), 2011 20
Table 4: QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Region, Revenue ($m) and Market Share (%), 2011 21
Table 5: QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Country, Revenue ($m) and Market Share (%), 2011 22
Table 6: QuadraMed Corporation, Key Employees 23
Table 7: QuadraMed Corporation, Deals Volume Summary, 2006 to YTD 2012 27
Table 8: QuadraMed Corporation, Deals Summary, 2006 to YTD 2012 28
Table 9: QuadraMed Acquires Healthcare Solutions Business From NCR 29
Table 10: Francisco Partners Completes Acquisition Of Quadramed 31
Table 11: Nuance Communications To Acquire Quantim, Health Information Management Business Of QuadraMed 33
Table 12: USD to Local Currency, Average Exchange Rate, 2011 44

1.2 List of Figures
Figure 1: Healthcare IT (Clinical IT Systems), Global, Market Share (%), 2011 19
Figure 2: QuadraMed Corporation, Healthcare IT (Clinical IT Systems), by Country, Market Share (%), 2011 22
Figure 3: QuadraMed Corporation, Deals Volume Summary, 2006 to YTD 2012 27
  • Global Cystic Fibrosis Market Propelled by Technological Advancement
    With increasing prevalence of cystic fibrosis and its growing awareness among people, the global market for cystic fibrosis is expected to grow at a steady pace. Cystic fibrosis is a genetic condition where the lungs and digestive system becomes clogged with excess mucus. This condition is more common among Caucasian population than people of Asian [...]
  • Bright Prospects Ahead for the SONAR Systems and Technology Market
    With advancement of technology, the global SONAR systems and technology market is increasing at a rapid pace. SONAR which is an acronym for SOund Navigation And Ranging is a technique that uses sound propagation to navigate and communicate with objects on or under the surface of the water, such as other vessels. In 2014, the [...]
  • Increase in Surgical Procedures Propelling the Anesthesia Drugs Market
    With increase in surgical operations and invasive medical tests, the market for anesthesia drugs has been growing at a steady pace. Anesthesia drugs can be broadly categorized into two types – general anesthesia drugs and local anesthesia drugs. Anesthetic drugs help in inducing sleep and preventing discomfort and pain during surgical procedures. By 2018, the [...]
  • Water Treatment Chemicals Market to be driven by Increasing Demand from Developing Economies
    The global market for water treatment chemicals is growing at a steady pace with rapid urbanization and high demand from end-users. Water treatment chemicals are used for treating municipal water as well as agricultural wastewater. With higher demand for clean, drinking water with increasing population and increase in the number of industries, the global market [...]
  • Rise in Prevalence of Allergic Diseases Driving the Global Allergy Diagnostics Market
    With rise in the incidences of allergic diseases in the world, the global allergy diagnostics market has also witnessed steady growth. In recent years, there has been an increase in the number of people suffering from different allergies, particularly food allergies and drug allergies. The number of people suffering from asthma has also increased in [...]
  • To bring in Photography to the Real World Visual Supply Co Acquires Artifact Uprising
  • Visual Supply Co, VSCO has brought a Denver-based startup, Artifact Uprising, which is focused on bringing photographers’ work from the digital hubs on regular basis by modern creatives to the real world as prints and tangible books. Artifact Uprising is …

  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Peripheral Neuropathy (Sensory Neuropathy) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Peripheral Neuropathy (Sensory Neuropathy) - Pipeline Review, H1 2015', provides an overview of the Peripheral Neuropathy (Sensory Neuropathy)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Peripheral Neuropathy (Sensory Neuropathy), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along wit......
  • Polycystic Ovarian Syndrome – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Polycystic Ovarian Syndrome - Pipeline Review, H1 2015', provides an overview of the Polycystic Ovarian Syndrome's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Polycystic Ovarian Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press......
  • Dyslipidemia – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Dyslipidemia - Pipeline Review, H1 2015', provides an overview of the Dyslipidemia's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Dyslipidemia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players invo......
  • Growth Hormone Deficiency – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Growth Hormone Deficiency - Pipeline Review, H1 2015', provides an overview of the Growth Hormone Deficiency's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Growth Hormone Deficiency, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press relea......
  • Acute Heart Failure – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Acute Heart Failure - Pipeline Review, H1 2015', provides an overview of the Acute Heart Failure's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Acute Heart Failure, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also revie......
  • Endometriosis – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Endometriosis - Pipeline Review, H1 2015', provides an overview of the Endometriosis's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Endometriosis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players inv......
  • Proliferative Vitreoretinopathy (PVR) – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Proliferative Vitreoretinopathy (PVR) - Pipeline Review, H1 2015', provides an overview of the Proliferative Vitreoretinopathy (PVR)'s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Proliferative Vitreoretinopathy (PVR), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest update......
  • Diabetic Peripheral Neuropathy – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Diabetic Peripheral Neuropathy - Pipeline Review, H1 2015', provides an overview of the Diabetic Peripheral Neuropathy's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Diabetic Peripheral Neuropathy, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ......
  • Kaposi’s Sarcoma – Pipeline Review, H1 2015
    Published: 23-Jan-2015        Price: US $2000 Onwards        
    Global Markets Direct's, ‘Kaposi's Sarcoma - Pipeline Review, H1 2015', provides an overview of the Kaposi's Sarcoma's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Kaposi's Sarcoma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs